NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/03/2023
Back to search
Official data from USPTO
EXOTHERA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EXOTHERA
ST13
US500000079296890Class
40, 42
Filing
79296890
Registration
6458341
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
06/03/2023
Trademark type
Word
Nice classes
40, 42
Filing date
09/18/2020
Registration date
08/24/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/24/2021
Last transaction
08/24/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
BE
Examiner
STRUCK, ROBERT
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
EXOTHERA, société anonyme
Representatives
Andrew D. Dorisio DICKINSON WRIGHT PLLC
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacturing of biologicsmanufacturing of biologics using biological organisms in the manufacturing process; custom manufacturing of pharmaceuticalsantibiotic medicines and materials for clinical trials and for commercial supply by pharmaceutical compounders; bio manufacturing for otherscustom manufacturing of pharmaceuticals and materials for clinical trials for commercial supplyusing biological organisms in the manufacturing process; custom manufacturing services in the field of biologicspharmaceuticalsbiopharmaceuticalshealth carecell culture and gene therapy and medical products; custom manufacturing of medications and parts of medications on the base of specific compositions or active constituents for others to support clinical trials and commercial supply; treatment of pharmaceutical and chemical products and their components during the custom manufacture of pharmaceuticals and biopharmaceuticals; providing advice related to the custom manufacture of pharmaceuticals and materials for clinical trials and for commercial supply; providing information in the field of the custom manufacture of pharmaceuticals and materials for clinical trials and for commercial supply
Class 42
Scientific research and development applied in particular in the biologicaltechnological and biotechnological fieldsin the medicalbiomedicalchemicalpharmaceutical and veterinary fieldsin the fields of immunologyepidemiologyvaccinology and therapies and in the field of gene and cellular therapy; scientific and technological research and development for the pharmaceutical and biotechnology industries; quality control services on pharmaceutical products for others; scientific research and technological development and advice servicesanalytical testingbiosafety testingreporting and laboratory services for otherscustom design and development of chemical reagents and biochemical assaysformulation and process development for the manufacturing of medicinal products; engineering services; scientific and technological consultancy on process development relating to manufacture of biologics; industrial process development for manufacturing of medical preparations; engineering services and scientific and technological consultancyall on production units for the development of biologics; design of tools for the production of biologics; advisory services relating to industrial engineering in the field of manufacturing of biologics; biochemical engineering services; technical engineering services in the field of manufacturing of biologics; rental of laboratory apparatus and instruments; technological development servicestechnology advice and information services and engineering consultation services in the field of the production of biologics; scientific research services in the medical sectorconducting clinical trials for others; providing scientific research information in the medical sectorin the field of clinical trials; scientific laboratory services related to the culture of stem cells or differentiated cells and biological materials to be used in cellular therapies and in clinical trials and for the manufacturing of commercial products
Publications
History of USPTO decisions and trademark events.
26 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/28/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/04/2022
FIMP
FINAL DISPOSITION PROCESSED
02/03/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/24/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/24/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/29/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/29/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/29/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/08/2021
PUBO
PUBLISHED FOR OPPOSITION
06/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/19/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/09/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/06/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/29/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/28/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/28/2021
RFNT
REFUSAL PROCESSED BY IB
03/22/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/26/2021
RFRR
REFUSAL PROCESSED BY MPU
02/26/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/06/2021
CNRT
NON-FINAL ACTION WRITTEN
02/05/2021
DOCK
ASSIGNED TO EXAMINER
02/03/2021
MAFR
APPLICATION FILING RECEIPT MAILED
11/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/02/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/29/2020
Continuous trademark protection
Get notified about every new filing that threatens EXOTHERA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.